Ads by Google
Health care professional and doctors now can use their iPhones to lookup for drugs and see why or how a particular drug is prescribed. The drug view list (probably available in your 3G iPhone too) will populate around 3,300 most commonly prescribed drugs and give instant information about them.
The program will show the drug usage, dosing information directly on your iPhone screen. One in four doctors in USA use Epocrates products.
FDAAA to require manufacturers of "conventional" antipsychotic drugs to make safety-related changes to prescribing information, or labeling, to warn about an increased risk of death associated with the off-label use of these drugs to treat behavioral problems in older people with dementia.
ETHEX has voluntarily recalled specific additional lots of morphine sulfate 60 mg extended release tablets, and specific lots of morphine sulfate 30 mg extended release tablets, as a precaution, due to the possible presence of oversized tablets.
Lupin Pharmaceuticals has received tentative approval for ANDA for Escitalopram Oxalate Tablets 10 mg and 20 mg from USFDA.
In the first use of a framework allowing submission of a single application to the two agencies, FDA and EMEA worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs.
ETHEX Corporation has voluntarily recalled a single lot of morphine sulfate 60 mg extended release tablets (Lot No. 91762) due to a report of a tablet with twice the appropriate thickness.
Oversized tablets may contain as much as two times the labeled level of active morphine sulfate. The lot was distributed by ETHEX Corporation under an "ETHEX" label between April 16th and April 27th of 2008. No other dosage strength, nor any other lot of the 60 mg strength is affected by this recall.
FDA announced the addition of a boxed warning to the label of Regranex Gel 0.01% to address the increased risk of cancer mortality in patients who use 3 or more tubes of the product.